186 related articles for article (PubMed ID: 11746108)
1. Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma.
Reuther T; Kübler AC; Zillmann U; Flechtenmacher C; Sinn H
Lasers Surg Med; 2001; 29(4):314-22. PubMed ID: 11746108
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ
Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737
[TBL] [Abstract][Full Text] [Related]
3. mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Horlings RK; Terra JB; Witjes MJ
Lasers Surg Med; 2015 Dec; 47(10):779-87. PubMed ID: 26462858
[TBL] [Abstract][Full Text] [Related]
4. Endobronchial photodynamic therapy: comparison of mTHPC and polyethylene glycol-derived mTHPC on human tumor xenografts and tumor-free bronchi of minipigs.
Ris HB; Im Hof V; Stewart CM; Mettler D; Altermatt HJ
Lasers Surg Med; 1998; 23(1):25-32. PubMed ID: 9694147
[TBL] [Abstract][Full Text] [Related]
5. Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro.
Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
Int J Cancer; 2002 Apr; 98(5):793-8. PubMed ID: 11920653
[TBL] [Abstract][Full Text] [Related]
6. mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review.
de Visscher SA; Dijkstra PU; Tan IB; Roodenburg JL; Witjes MJ
Oral Oncol; 2013 Mar; 49(3):192-210. PubMed ID: 23068024
[TBL] [Abstract][Full Text] [Related]
7. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy.
Braichotte DR; Savary JF; Monnier P; van den Bergh HE
Lasers Surg Med; 1996; 19(3):340-6. PubMed ID: 8923430
[TBL] [Abstract][Full Text] [Related]
8. [Clinical effectiveness of m-THPC-PEG in a new xenogenic animal tumor model for human squamous epithelial carcinomas].
Kübler AC; Reuther T; Staff C; Haase T; Flechtenmacher C; Benner A; Scheer M; Zillmann U
Mund Kiefer Gesichtschir; 2001 Mar; 5(2):105-13. PubMed ID: 11372175
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal photodynamic therapy in the rat: comparison of toxicity profiles for photofrin and MTHPC.
Veenhuizen RB; Ruevekamp-Helmers MC; Helmerhorst TJ; Kenemans P; Mooi WJ; Marijnissen JP; Stewart FA
Int J Cancer; 1994 Dec; 59(6):830-6. PubMed ID: 7989125
[TBL] [Abstract][Full Text] [Related]
10. Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Krueger T; Altermatt HJ; Mettler D; Scholl B; Magnusson L; Ris HB
Lasers Surg Med; 2003; 32(1):61-8. PubMed ID: 12516073
[TBL] [Abstract][Full Text] [Related]
11. Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma.
Westerman P; Glanzmann T; Andrejevic S; Braichotte DR; Forrer M; Wagnieres GA; Monnier P; van den Bergh H; Mach JP; Folli S
Int J Cancer; 1998 Jun; 76(6):842-50. PubMed ID: 9626351
[TBL] [Abstract][Full Text] [Related]
12. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
[TBL] [Abstract][Full Text] [Related]
14. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies.
Ris HB; Altermatt HJ; Nachbur B; Stewart CM; Wang Q; Lim CK; Bonnett R; Althaus U
Lasers Surg Med; 1996; 18(1):39-45. PubMed ID: 8850464
[TBL] [Abstract][Full Text] [Related]
16. Experimental assessment of photodynamic therapy with chlorins for malignant mesothelioma.
Ris HB; Giger A; Hof VI; Mettler D; Stewart JC; Althaus U; Altermatt HJ
Eur J Cardiothorac Surg; 1997 Oct; 12(4):542-8. PubMed ID: 9370396
[TBL] [Abstract][Full Text] [Related]
17. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
18. Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2008 Jul; 40(5):300-11. PubMed ID: 18563776
[TBL] [Abstract][Full Text] [Related]
19. Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy.
Vrouenraets MB; Visser GW; Stewart FA; Stigter M; Oppelaar H; Postmus PE; Snow GB; van Dongen GA
Cancer Res; 1999 Apr; 59(7):1505-13. PubMed ID: 10197621
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]